首页> 外文期刊>International Journal of Ayurvedic Medicine >Efficacy of Shankhapushpi Choorna on Borderline IQ in School Going Children - A Randomized Placebo Controlled Clinical Study
【24h】

Efficacy of Shankhapushpi Choorna on Borderline IQ in School Going Children - A Randomized Placebo Controlled Clinical Study

机译:Shankhapushpi Choorna在学校临时智商临界智商的疗效 - 随机安慰剂控制临床研究

获取原文
           

摘要

Objective: To study the concepts regarding Medha, Medhya and IQ. Detailed assessment of IQ level of school going children with 6-8 years of age group. To study the efficacy of Shankhapushpi Choorna in the enhancement of IQ of school going children with Borderline IQ. Design: Open randomized placebo controlled clinical study with pre and post-test design. Setting: O.P.D. of Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Udupi and also nearby schools of Udupi. Interventions: A minimum of 40 children under borderline IQ were selected based on the inclusion and exclusion criteria. The selected children were randomly divided into 2 groups of 20 each. Group A (Trial Group) were treated with Shankhapushpi Choorna with dose of 5grams daily at night, after food with lukewarm milk for a duration of 60 days and Group B was administered with Placebo. The follow up period was 30 days after the intervention. Main outcome measures: The subjective criteria were based on the parameters of Grasping power, Memory power, Courage & Activity.? The values obtained using Malin’s Intelligence Scale for Indian Children (MISIC) were considered for objective assessment. Results: Over the duration of the study, the trial drug Shankhapushpi Choorna was seen to have a positive effect on all the subjective and objective parameters with statistically highly significant results. Conclusion: Shankhapushpi Choorna with the proper dosage according to the age definitely improves the Medha of children with borderline IQ. The drug can be used as both promotive as well as curative aspects in accordance with intelligence.
机译:目的:研究有关MEDHA,METHYA和IQ的概念。 6-8岁年龄段的学校思考儿童智商的详细评估。研究Shankhapushpi Choorna在临界智商诊所智商智商增强的疗效。设计:具有前后设计的开放随机安慰剂控制临床研究。设置:o.p.d.斯里·达马西塔省曼君达达·阿育吠陀与医院学院,乌杜普,以及附近的Udupi学校。干预措施:根据纳入和排除标准,选择濒临边界IQ下的40名儿童。将所选儿童随机分为2组。 A组(试验组)用Shankhapushpi Choorna治疗,每天每天用5克的剂量治疗,在持续60天持续60天的食物中,B组被安慰剂施用。干预后的后续期间是30天。主要结果措施:主观标准是基于掌握电力,记忆力,勇气和活动的参数。使用Malin的印度儿童(MISIC)获得的价值被认为是客观评估。结果:在研究期间,试验药物Shankhapushpi Choorna被认为对所有主观和客观参数具有统计学高度显着效果的积极影响。结论:Shankhapushpi Choorna根据年龄的适当用量肯定改善了边境智商的儿童Medha。药物可以根据智力用作促进和疗效方面。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号